Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Advani SJ et al (1998) Enhancement of replication of genetically engineered herpes simplex viruses by ionizing radiation: a new paradigm for destruction of therapeutically intractable tumors. Gene Ther 5:160–165
Agnihotri SA et al (2004) Recent advances on chitosan-based micro-and nanoparticles in drug delivery. J Control Release 100:5–28
Arap W et al (1998) Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science 279:377–380
Arap W et al (2002) Steps toward mapping the human vasculature by phage display. Nat Med 8:121–127
Augustin HG (2003) Translating angiogenesis research into the clinic: the challenges ahead. Br J Radiol 76 (Spec No 1):S3–S10
Avgoustakis K (2004) Pegylated poly (lactide) and poly (lactideco-glycolide) nanoparticles: preparation, properties and possible applications in drug delivery. Curr Drug Deliv 1:321–333
Bibikova M et al (2004) Quantitative gene expression profiling in formalin-fixed, paraffin-embedded tissues using universal bead arrays. Am J Pathol 165:1799–1807
Bisacchi D et al (2003) Anti-angiogenesis and angioprevention: mechanisms, problems and perspectives. Cancer Detect Prev 27:229–238
Biston MC et al (2004) Cure of Fisher rats bearing radioresistant F98 glioma treated with cis-platinum and irradiated with monochromatic synchrotron X-rays. Cancer Res 64:2317–2323
Boder ET, Wittrup KD (1997) Yeast surface display for screening combinatorial polypeptide libraries. Nat Biotechnol 15:553–557
Borjesson J et al (1993) In vivo X-ray fluorescence analysis with applications to platinum, gold and mercury in man: experiments, improvements, and patient measurements. Basic Life Sci 60:275–280
Boulter JM, Jakobsen BK (2005) Stable, soluble, high-affinity, engineered T cell receptors: novel antibody-like proteins for specific targeting of peptide antigens. Clin Exp Immunol 142:454–460
Carlos TM, Harlan JM (1994) Leukocyte-endothelial adhesion molecules. Blood 84:2068–2101
Carson-Walter EB et al (2001) Cell surface tumor endothelial markers are conserved in mice and humans. Cancer Res 61:6649–6655
Cesareni G et al (1999) Phage displayed peptide libraries. Comb Chem High Throughput Screen 2:1–17
Chen X et al (2004) Novel endothelial cell markers in hepatocellular carcinoma. Mod Pathol 17:1198–1210
Christian S et al (2003) Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels. J Cell Biol 163:871–878
Cox G et al (2004) Angiogenesis and non-small cell lung cancer. Lung Cancer 27:81–100
Dani M (2001) Peptide display libraries: design and construction. J Recept Signal Transduct Res 21:469–488
Davies G et al (2004) Levels of expression of endothelial markers specific to tumour-associated endothelial cells and their correlation with prognosis in patients with breast cancer. Clin Exp Metastasis 21:31–37
Davy A, Soriano P (2005) Ephrin signaling in vivo: look both ways. Dev Dyn 232:1–10
Demetriou MC et al (2004) Extracellular alpha 6 integrin cleavage by urokinase-type plasminogen activator in human prostate cancer. Exp Cell Res 294:550–558
Ebnet K, Vestweber D (1999) Molecular mechanisms that control leukocyte extravasation: the selectins and the chemokines. Histochem Cell Biol 112:1–23
Feng SS et al (2004) Nanoparticles of biodegradable polymers for clinical administration of paclitaxel. Curr Med Chem 11:413–424
Fernando NH, Hurwitz HI (2003) Inhibition of vascular endothelial growth factor in the treatment of colorectal cancer. Semin Oncol 30:39–50
Ferrari M (2005) Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer 5:161–171
Folkman J (1971) Tumor angiogenesis: therapeutic implications. N Engl J Med 285:1182–1186
Fonsatti E et al (2003) Emerging role of endoglin (CD105) as a marker of angiogenesis with clinical potential in human malignancies. Curr Cancer Drug Targets 3:427–432
Frankel A et al (2003) Unnatural RNA display libraries. Curr Opin Struct Biol 13:506–512
Friedman DB et al (2004) Proteome analysis of human colon cancer by two-dimensional difference gel electrophoresis and mass spectrometry. Proteomics 4:793–811
Fu C et al (2001) Identification of a novel membrane protein, HP59, with therapeutic potential as a target of tumor angiogenesis. Clin Cancer Res 7:4182–4194
Geng L et al (2004) Radiation-guided drug delivery to tumor blood vessels results in improved tumor growth delay. J Control Release 99:369–381
Georgiou G et al (1997) Display of heterologous proteins on the surface of microorganisms: from the screening of combinatorial libraries to live recombinant vaccines. Nat Biotechnol 15:29–34
Hainfeld JF et al (2004) The use of gold nanoparticles to enhance radiotherapy in mice. Phys Med Biol 49:N309–N315
Hallahan DE et al (1995) Spatial and temporal control of gene therapy using ionizing radiation. Nat Med 1:786–791
Hallahan DE et al (2001) Targeting drug delivery to radiation-induced neoantigens in tumor microvasculature. J Control Release 74:183–191
Hallahan D et al (2003) Integrin-mediated targeting of drug delivery to irradiated tumor blood vessels. Cancer Cell 3:63–74
Hallborn J, Carlsson R (2002) Automated screening procedure for high-throughput generation of antibody fragments. Biotech Suppl:30–37
Hanes J et al (1998) Ribosome display efficiently selects and evolves high-affinity antibodies in vitro from immune libraries. Proc Natl Acad Sci USA 95:14130–14135
Hardwick JS et al (2005) Identification of biomarkers for tumor endothelial cell proliferation through gene expression profiling. Mol Cancer Ther 4:413–425
Hofheinz RD et al (2005) Liposomal encapsulated anti-cancer drugs. Anticancer Drugs 16:691–707
Holt LJ et al (2003) Domain antibodies: proteins for therapy. Trends Biotechnol 21:484–490
Isayeva T et al (2004) Anti-angiogenic gene therapy for cancer (review). Int J Oncol 25:335–343
Joiner MC et al (2001) Low-dose hypersensitivity: current status and possible mechanisms. Int J Radiat Oncol Biol Phys 49:379–389
Joyce JA et al (2003) Stage-specific vascular markers revealed by phage display in a mouse model of pancreatic islet tumorigenesis. Cancer Cell 4:393–403
Kerbel RS (2000) Tumor angiogenesis: past, present and the near future. Carcinogenesis 21: 505–515
Khodarev NN et al (2003) Tumour-endothelium interactions in co-culture: coordinated changes of gene expression profiles and phenotypic properties of endothelial cells. J Cell Sci 116:1013–1022
Kim JM et al (2005) Identification of gastric cancer-related genes using a cDNA microarray containing novel expressed sequence tags expressed in gastric cancer cells. Clin Cancer Res 11:473–482
Kimura H et al (1995) Inhibition of radiation-induced up-regulation of leukocyte adhesion to endothelial cells with the platelet-activating factor inhibitor, BN52021. Int J Radiat Oncol Biol Phys 33:627–633
Klagsbrun M, Eichmann A (2005) A role for axon guidance receptors and ligands in blood vessel development and tumor angiogenesis. Cytokine Growth Factor Rev 16:535–548
Kortt AA et al (2001) Dimeric and trimeric antibodies: high avidity scFvs for cancer targeting. Biomol Eng 18:95–108
Kovar M et al (2002) Star structure of antibody-targeted HPMA copolymer-bound doxorubicin: a novel type of polymeric conjugate for targeted drug delivery with potent antitumor effect. Bioconjug Chem 13:206–215
Kukowska-Latallo JF et al (2005) Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer. Cancer Res 65:5317–5324
Laakkonen P et al (2004) Antitumor activity of a homing peptide that targets tumor lymphatics and tumor cells. Proc Natl Acad Sci USA 101:9381–9386
Lee CC et al (2005) Designing dendrimers for biological applications. Nat Biotechnol 23:1517–1526
Lee WS et al (1998) Thy-1, a novel marker for angiogenesis upregulated by inflammatory cytokines. Circ Res 82:845–851
Markland W et al (1991) Design, construction and function of a multicopy display vector using fusions to the major coat protein of bacteriophage M13. Gene 109:13–19
Marty C et al (2005) Isolation and characterization of a scFv antibody specific for tumor endothelial marker 1 (TEM1), a new reagent for targeted tumor therapy. Cancer Lett epub
McDonald WH, Yates JR (2002) Shotgun proteomics and biomarker discovery. Dis Markers 18:99–105
McNeil SE (2005) Nanotechnology for the biologist. J Leukoc Biol 78:585–594
Miettinen M et al (2005) Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up. Am J Surg Pathol 29:52–68
Mikawa YG (1996) Surface display of proteins on bacteriophage lambda heads. J Mol Biol 262:21–30
Mitra S et al (2001) Tumour targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan nanoparticles as carrier. J Control Release 74:317–323
Moghimi SM et al (2001) Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev 53:283–318
Molla M et al (1999) Influence of dose-rate on inflammatory damage and adhesion molecule expression after abdominal radiation in the rat. Int J Radiat Oncol Biol Phys 45:1011–1018
Mousa SA, Mousa AS (2004) Angiogenesis inhibitors: current and future directions. Curr Pharm Des 10:1–9
Muller OJ et al (2003) Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors. Nat Biotechnol 21:1040–1046
Nakshatri H et al (1996) Isolation of retinoic acid-repressed genes from P19 embryonal carcinoma cells. Gene 174:79–84
Nanda A, St. Croix B (2004) Tumor endothelial markers: new targets for cancer therapy. Curr Opin Oncol 16:44–49
Neufeld G et al (2002) The neuropilins: multifunctional semaphorin and VEGF receptors that modulate axon guidance and angiogenesis. Trends Cardiovasc Med 12:13–19
Neufeld G et al (2005) Semaphorins in cancer. Front Biosci 10:751–760
Osaki F et al (2004) A quantum dot conjugated sugar ball and its cellular uptake. On the size effects of endocytosis in the subviral region. J Am Chem Soc 126:6520–6521
Pang H et al (2004) Epidermal growth factor suppresses induction by progestin of the adhesion protein desmoplakin in T47D breast cancer cells. Breast Cancer Res 6:R239–R245
Pasqualini R, Ruoslahti E (1996) Organ targeting in vivo using phage display peptide libraries. Nature 380:364–366
Patri AK et al (2005) Targeted drug delivery with dendrimers: comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex. Adv Drug Deliv Rev 57:2203–2214
Peirce MJ et al (2004) Expression profiling of lymphocyte plasma membrane proteins. Mol Cell Proteomics 3:56–65
Pini A et al (2004) Strategies for the construction and use of peptide and antibody libraries displayed on phages. Curr Protein Pept Sci 5:487–496
Rmali KA et al (2005) TEM-8 and tubule formation in endothelial cells, its potential role of its vW/TM domains. Biochem Biophys Res Commun 334:231–238
Roberts RW, Szostak JW (1997) RNA-peptide fusions for the in vitro selection of peptides and proteins. Proc Natl Acad Sci USA 94:12297–12302
Rode HJ et al (1996) Cell surface display of a single-chain antibody for attaching polypeptides. Biotechniques 21(650):655–658
Roodink I et al (2003) Plexin D1 expression is induced on tumor vasculature and tumor cells: A novel target for diagnosis and therapy? Cancer Res 65:8317–8323
Ruoslahti E (2000) Targeting tumor vasculature with homing peptides from phage display. Semin Cancer Biol 10:435–442
Ruoslahti E (2004) Vascular zip codes in angiogenesis and metastasis. Biochem Soc Trans 32:397–402
Rybak JN et al (2005) In vivo protein biotinylation for identification of organ-specific antigens accessible from the vasculature. Nat Methods 2:291–298
Schlehuber S, Skerra A (2005) Anticalins as an alternative to antibody technology. Expert Opin Biol Ther 5:1453–1462
Scott JK, Smith GP (1990) Searching for peptide ligands with an epitope library. Science 249:386–390
Sengupta S et al (2005) Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system. Nature 436:568–572
Shin BK et al (2003) Global profiling of the cell surface proteome of cancer cells uncovers an abundance of proteins with chaperone function. J Biol Chem 278:7607–7616
Sidhu SS (2000) Phage display in pharmaceutical biotechnology. Curr Opin Biotechnol 11:610–616
Smith GP (1985) Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 228:1315–1317
Sridhar SS, Shepherd FA (2003) Targeting angiogenesis: a review of angiogenesis inhibitors in the treatment of lung cancer. Lung Cancer 42(Suppl 1):S81–S91
St. Croix B et al (2000) Genes expressed in human tumor endothelium. Science 289:1197–1202
Terashima M et al (2005) Gene expression profiles in human gastric cancer: expression of maspin correlates with lymph node metastasis. Br J Cancer 92:1130–1136
Thorpe PE (2004) Vascular targeting agents as cancer therapeutics. Clin Cancer Res 10:415–427
Van Valckenborgh E et al (2005) Targeting an MMP-9-activated prodrug to multiple myeloma-diseased bone marrow: a proof of principle in the 5T33MM mouse model. Leukemia 19:1628–1633
Vinogradov SV et al (2004) Nanogels for oligonucleotide delivery to the brain. Bioconjug Chem 15:50–60
Wang B et al (2005) Conserved molecular players for axon guidance and angiogenesis. Curr Protein Pept Sci 6:473–478
Weichselbaum RR et al (1994) Gene therapy targeted by radiation preferentially radiosensitizes tumor cells. Cancer Res 54:4266–4269
Wickham TJ et al (1995) Targeting of adenovirus penton base to new receptors through replacement of its RGD motif with other receptor-specific peptide motifs. Gene Ther 2:750–756
Winkler F et al (2004) Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases. Cancer Cell 6:553–563
Wu NZ et al (1994) Differences in leucocyte-endothelium interactions between normal and adenocarcinoma bearing tissues in response to radiation. Br J Cancer 69:883–889
Wulfkuhle JD et al (2003) Proteomic applications for the early detection of cancer. Nat Rev Cancer 3:267–275
Yamamoto M (1999) Phage display cDNA cloning of protein with carbohydrate affinity. Biochem Biophys Res Commun 255:194–199
Yoo HS et al (2000) In vitro and in vivo anti-tumor activities of nanoparticles based on doxorubicin-PLGA conjugates. J Control Release 68:419–431
Yuan H et al (2003) Radiation-induced permeability and leukocyte adhesion in the rat blood-brain barrier: modulation with anti-ICAM-1 antibodies. Brain Res 969:59–69
Zhang L et al (2005) Molecular profiling of heart endothelial cells. Circulation 112:1601–1611
Zhang X et al (2004) Enhancement of hypoxia-induced tumor cell death in vitro and radiation therapy in vivo by use of small interfering RNA targeted to hypoxia-inducible factor-1alpha. Cancer Res 64:8139–8142
Zurita AJ et al (2003) Mapping tumor vascular diversity by screening phage display libraries. J Control Release 91:183–186
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Han, Z., Hariri, G., Hallahan, D.E. (2006). Radiotherapy and Tumor-Targeted Drug Delivery. In: Brown, J.M., Mehta, M.P., Nieder, C. (eds) Multimodal Concepts for Integration of Cytotoxic Drugs. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-35662-2_11
Download citation
DOI: https://doi.org/10.1007/3-540-35662-2_11
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-25655-7
Online ISBN: 978-3-540-35662-2
eBook Packages: MedicineMedicine (R0)